Table 4.

Significant associations between variables from different parts of the hypothesized mechanism

	Echocardiography	Cardiac biomarkers		Insulin, glucose, IGF‐1	SAA
		NT‐proBNP	c‐TnI
Age				Glucose (ρ = 0.31, P = .03)
BW	n‐LVWd (ρ = 0.29, P = .04)			IGF‐1 (r = 0.44, P = .001)
BCS				Insulin (ρ = 0.33, P = .02) Glucose (ρ =0.29, P = .04) IGF‐1 (ρ = 0.32, P = .02)
IVSd		Max‐IVSd (ρ = 0.32, P = .05)			n‐IVSd (ρ = 0.28, P = .05)
LVWd		Max‐LVWd (ρ = 0.41, P = .01)
LA		LA/Ao (ρ = 0.52, P = .001) LAmax (ρ = 0.32, P = .05) LA remodeling (ρ = 0.38, P = .02)	LA/Ao (ρ = 0.49, P = .001) LAmax (ρ = 0.28, P = .05) LA remodeling (ρ = 0.38, P = .01)

Abbreviations: BCS, body condition score; BW, body weight; cTnI, cardiac troponin‐I; IGF‐1, insulin‐like growth factor‐1; LA/Ao, left atrium to aorta ratio; LA‐max, maximum diameter of left atrium; Max‐IVSd, maximum thickness of interventricular septum in diastole; Max‐LVWd, maximum thickness of left ventricular free wall in diastole; n‐IVSd, number of regions in interventricular septum in diastole ≥6 mm; n‐LVWd, number of regions of left ventricular free wall in diastole ≥6 mm; SAA, serum amyloid A.